stricture recurrence, the repeat procedures were dilatation in 56% of cases, urethrotomy in 41% and urethroplasty in 3.6%. 1 Data from the National Health Service in the UK during 2006 showed that the procedures used to treat strictures were urethrotomy or dilatation in 93% of cases and urethroplasty in only 7%. 2 A survey among urologists in the USA in 2002 showed that 93% used dilatation and 86% optical urethrotomy, whereas 58% performed urethroplasty for the treatment of urethral strictures. Overall, 35% performed 1 -5 urethroplasties a year and only 0.7% performed more than 11 a year. 3, 4 An analysis of Medicare patients in the USA treated for urethral strictures in the period 1992 -2001 showed that urethrotomy comprised 51 -58% of procedures performed, dilatation 35 -44% and urethroplasty only 0.5 -0.8%. 5 The authors pointed out that if the estimated success rate is 95% for urethroplasty and 50% for urethrotomy, the ratio of urethrotomies to urethroplasties performed should be approximately 2:1, and if the success rate of urethrotomy is assumed to be 20%, the ratio should 5:4, much lower than the rates of 10:1 and even 50:1 reported in the literature. 5 Earlier studies suggested that repeated urethrotomy for recurrent urethral strictures may serve to 'stabilise' the stricture, thereby increasing the cumulative success rate. 6, 7 However, since the early 1980s some authors have reported that a second urethrotomy had a lower success rate and that repeated urethrotomy did not improve the cumulative success rate. 8, 9 A prospective randomised study performed at our hospital during the period January 1991 -January 1994 compared filiform dilatation (n=106 patients) with optical urethrotomy (n=104) as treatment for male urethral strictures. 10 The study compared the stricture recurrence rate among those who had only 1 treatment at study entry, those who had a repeated procedure for stricture recurrence at 3 months, and those who underwent a third treatment for recurrences at 3 and 6 months after initial treatment. In patients not treated before randomisation the estimated stricture-free rate after 1, 2 or 3 repeated treatments was approximately 60%, 40% and 0% at 24 months, and about 50%, 40% and 0% at 48 months. After a single dilatation or urethrotomy not followed by re-stricturing at 3 months, the estimated stricture-free rate was 55 -60% at 24 months and 50 -60% at 48 months. 10 A study of patients in the UK treated during the period 1991 -1999 suggested that a strategy of initial urethrotomy or dilatation Results. The mean age of the 125 men was 49.9 years (range 12.8 -93.4 years). Previous stricture treatment had been given 1 -2, 3 -4 and 5 -6 times in 52%, 32% and 12% of patients, respectively (4% had not undergone treatment). In these groups, previous treatment was dilatation in 70%, 76% and 72%, urethrotomy in 26%, 15% and 28%, and urethroplasty in 4%, 9% and 0, respectively. The group with 5 -6 compared with 1 -2 previous treatments was significantly older (mean age 60.2 v. 46.6 years) and had a significantly greater proportion with underlying co-morbidities (80% v. 52%). The group that had undergone urethroplasty compared with 5 -6 repeated dilatations or urethrotomies was significantly younger (mean age 48.2 v. 60.2 years) with a lower prevalence of co-morbidities (47% v. 80%). During the study period urethroplasty was performed in 16 (2%) of 821 inpatients, whereas 55 men were seen who had undergone ≥3 previous procedures, indicating that urethroplasty was performed in less than one-third of cases in which it would have been the optimal treatment. Owing to limited theatre time, procedures indicated for malignancy, urolithiasis, renal failure and congenital anomalies were performed more often than urethroplasty.
Conclusions. Factors that possibly influenced the decision to perform repeated urethrotomy or dilatation instead of urethroplasty were limited theatre time, increased patient age and the presence of underlying co-morbidities. 
SAJS
followed by urethroplasty for recurrent stricture is the most cost-effective strategy. 1 In contrast, a study from the USA using a cost minimisation decision analysis model for the treatment of a 2 cm bulbar stricture suggested that urethrotomy was more costly than immediate urethroplasty, unless the estimated longterm success of urethrotomy was greater than 40%. 11 A study from the USA considered the costs of treatment as well as lost wages from convalescence and suggested that in the case of a 1 -2 cm bulbar urethral stricture the strategy of one urethrotomy before proceeding to urethroplasty was the least costly, unless the expected success rate of urethrotomy was less than 35%. 12 It has been suggested that the reasons for utilisation of repeated urethrotomy are lack of urethroplasty expertise among urologists and perverse financial incentives preventing the referral of patients to centres with expertise. 13 In the USA, physician reimbursement for urethroplasty is approximately twice the amount for urethrotomy, suggesting that there is a financial disincentive to performing urethroplasty. 3 Despite evidence on the limited usefulness of repeated dilatation and urethrotomy provided by the randomised controlled trial in our hospital, it remains unknown whether this evidence has been applied in practice. The aim of this study was to determine the prevalence of, and possible reasons for, the use of repeated dilatation or urethrotomy rather than urethroplasty in our hospital.
Patients and methods
Male patients attending the stricture clinic of the general urological service at out institution (a tertiary-level public sector academic teaching hospital serving a largely indigent population without private medical insurance) were interviewed using a structured questionnaire on demographic, socio-economic and clinical aspects of the subject's medical history. Additional information about stricture aetiology and management was obtained from the patient's medical records.
Patients referred to the stricture clinic included all untreated men with a newly diagnosed or suspected urethral stricture, and all men followed up after previous stricture treatment. All patients had been treated at our hospital, and were not referred because of failed stricture treatment elsewhere. Apart from a full history and clinical examination, evaluation included the international prostate symptom score (IPSS), uroflowmetry and ultrasound measurement of the post-void residual. The urethra was evaluated by calibration using Jacques or Nelaton catheters in all patients. Retrograde and/or prograde urethrography and flexible or rigid urethrocystoscopy was performed in patients when the F18 catheter could not be passed. Stricture was defined as a urethral lumen less than F18 in diameter.
Treatment decisions were made in consultation with patients on an individual basis and not according to a rigid protocol. Most of the patients evaluated during the study period had been treated SAJS previously by several different urology specialists and residents in our hospital over the course of several years, with no consistent documentation of the reason(s) for specific treatment decisions. Follow-up after treatment was usually scheduled at 3, 6 and 12 months and annually thereafter if no stricture recurrence was found. After every retreatment, follow-up was rescheduled at 3, 6 and 12 months and annually thereafter. The operative procedures performed on inpatients in the main urology theatres during the period of this survey were also analysed to determine the number of urethroplasties performed.
The study protocol for the perusal of medical records was approved by the local institutional review board, and written informed consent for completion of the structured questionnaire was obtained from all study subjects.
All data were entered on an Excel spreadsheet. Statistical analysis was performed using GraphPad Instat software. Student The causes of the strictures were classified as previous urethritis (infective/inflammatory), external trauma (perineal or straddle injury, pelvic fracture or gunshot wound), internal (iatrogenic) trauma (catheterisation or transurethral resection) and idiopathic (Table 1) . Overall, stricture location was bulbar in 76%, penile in 34%, membranous in 22% and meatal in 10% (some strictures involved more than one part of the urethra). The stricture was Stricture-free at last follow-up (%) 65 48 50 single in 76% of cases, and the mean stricture length was 1.6 cm (median 1.0, range 0.5 -5 cm), the length being 2 cm or less in 56% of cases. A comparison of the clinical findings according to stricture aetiology is shown in Table 1 .
Overall co-morbidities in the study cohort included hypertension (25%), previous or current tuberculosis (18%), renal failure (11%), ischaemic heart disease (9%), obstructive airway disease (8%), erectile dysfunction (8%), cancer (7%), diabetes mellitus (6%), epilepsy (4%), arthritis (4%), brain damage (3%) and depression (2%) (some patients had more than one co-morbidity).
At the time of evaluation, 4% of patients had not undergone treatment, and 52% had undergone 1 -2 and 44% 3 -6 previous stricture treatments. The stricture aetiology, co-morbidities and clinical findings were compared according to the number of previous stricture treatments ( Table 2 ). The patient groups with previous urethroplasty and those with 5 -6 previous dilatations or urethrotomies were compared with each other (Table 3) . Among the patients who had undergone urethroplasty, subsequent dilatation or urethrotomy was performed 1 -2 times in 53%, 3 -4 times in 27% and not at all in 20%.
During the period April 2007 -March 2008 a total of 831 inpatients underwent a total of 1 313 urological procedures in the main operating theatre of our hospital (Table 4 ).
Discussion
The current study presents a cross-section of men with a diagnosis of urethral stricture evaluated during the course of a year in the general urological service of a tertiary-level academic hospital. The study cohort probably comprised a selected population, because men who were symptom-free after previous stricture treatment were probably less likely to comply with scheduled follow-up, whereas patients with symptoms due to stricture recurrence were more likely to attend. The results of prior treatment were therefore probably biased towards failed rather than successful treatment.
During the study period there were 55 men who had had 3 or more previous stricture treatments. During the same period, urethroplasty was performed on 16 patients, 2% of the total number who underwent inpatient urological operations (Table  4) . This means that, on average, less than one-third of men who should have had a urethroplasty did in fact undergo the procedure. A previous study showed that during the period 1975 -2002 the average annual number of inpatient operative urological procedures performed in our hospital decreased by a third, largely due to a 35% reduction in bed numbers and theatre time resulting from budgetary restrictions. Clearly, limited operating time is a major factor in selecting patients for surgery. Whereas urethral stricture disease affects the patient's quality of life and may lead to serious complications, it is rarely life-threatening. The procedures performed more often than urethroplasty in our hospital were mainly indicated for malignancy, urolithiasis, renal failure and congenital anomalies (Table 4) . Although repeated dilatation or internal urethrotomy is not optimal treatment, its continued use in our hospital is at least partly determined by selection pressures due to limited operating time. The reasons for the widespread use of repeated dilatation or urethrotomy rather than urethroplasty reported in the USA and the UK remain unknown, because no published studies have directly examined this question. However, limited operating room time due to budgetary constraints is unlikely to be an important reason.
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In this study cohort, 3 or more procedures were performed in a greater proportion of men with strictures caused by iatrogenic (58%) or external trauma (50%) than urethritis (31%). Mean follow-up was significantly shorter in the group with strictures caused by external trauma, possibly because younger men are less likely to return for routine follow-up if asymptomatic. Another possible explanation of the shorter follow-up is that traumatic strictures that recur after treatment do so within a shorter period of time than strictures with other causes (Table 1) .
In this study 44% of the men had undergone 3 -6 previous stricture treatments. Dilatation was the most common form of treatment (70 -76%), urethrotomy was used less often (15 -28%) and urethroplasty was used least often (4 -9%), and never as a 5th or 6th procedure (Table 2) . Compared with those who had undergone 1 -2 procedures, the group of men who had undergone 5 -6 procedures were significantly older (60.2 v. 46.6 years), had a greater proportion with iatrogenic strictures (67% v. 29%), underlying co-morbidities (80% v. 52%) and involvement of the penile urethra (53% v. 34%) and meatus (27% v. 3%) rather than the membranous urethra (13% v. 25%), and had a greater mean stricture length (2.2 v. 1.3 cm) and significantly longer follow-up, but no significant difference was noted with regard to stricturefree rate at last follow-up (50% v. 65%) ( Table 2) .
A recent paper by Santucci and Eisenberg reported that in 136 patients who underwent urethrotomy during the period 1994 -2009 at a centre in the USA the stricture-free rates after 1, 2, 3, 4 and 5 urethrotomies were 8%, 6%, 9%, 0% and 0%, respectively, much lower success rates than previously reported. 13 However, the analysis was based on only 76 (56%) of the patients who underwent urethrotomy, because the authors excluded 36 patients with complex strictures and 24 who were lost to followup. It is probable that patients lost to follow-up were stricture-free, whereas those with recurrence returned for further treatment. Moreover, the study cohort was probably a highly selected group with stricture recurrence after repeated urethrotomy, referred to a centre with expertise in urethroplasty. 13 Interestingly, the mean age of the patients in the above study increased with the number of urethrotomies, being 53, 57, 61, 68 and 74 years in those who had undergone 1, 2, 3, 4 and 5 previous urethrotomies, respectively. 13 This indicates that the decision to perform repeated urethrotomy was probably influenced by the patient's age and possibly by other undefined factors. The low success rates of first and second urethrotomy in this study (8% and 6%) are at variance with a large body of evidence in the literature, where the success rates range from 20% to 80%. 15 In the current study the use of repeated procedures was associated with significantly increasing patient age and an increasing prevalence of co-morbidities. The significantly longer follow-up in the groups with repeated treatment indicates a greater tendency to stricture recurrence with longer follow-up (Table 3) . Presumably many (if not most) patients who remained recurrencefree after initial treatment would not have returned for follow-up. This is the most probable explanation for the similar stricturefree rates at last follow-up, regardless of the number of previous treatments (Table 3) .
Factors associated with urethroplasty rather than repeated dilatation or urethrotomy (5 -6 times) included younger age (48.2 v. 60.2 years), external trauma rather than iatrogenic trauma as aetiology (33% v. 0% and 33% v. 67%, respectively), lower prevalence of co-morbidities (47% v. 80%), and membranous rather than penile location of the stricture (27% v. 13% and 33% v. 53%, respectively) ( Table 3 ). The fact that dilatation or urethrotomy was performed 1 -4 times after urethroplasty in 80% of these patients indicates selection bias towards men with stricture recurrence after urethroplasty, who were more likely to return for follow-up than those remaining stricture-free. This probably also explains the similar stricture-free rate at last followup after urethroplasty compared with 5 -6 repeated endoscopic procedures (56% v. 50%).
This study has some limitations. Although patients were prospectively evaluated during the course of a year, the assessment of previous stricture treatment was retrospective and based on clinical records. Since it was not a prospective follow-up study of all patients who underwent each of the treatment modalities, and because asymptomatic patients were probably less likely to return for long-term routine follow-up, the stricture-free rates found at follow-up do not reflect treatment efficacy, and are probably biased towards treatment failure rather than success. However, the factors determining selection bias were probably the same for all patients, regardless of previous treatment, which confers validity to the comparison of the treatment groups. Unfortunately, the reason(s) for performing repeated dilatation or urethrotomy rather than urethroplasty were not specifically recorded by the treating surgeons, so the reasons for treatment choices can only be inferred from analysis of the data.
Conclusions
Factors that probably influenced the decision to perform repeated urethrotomy or dilatation instead of urethroplasty in this study were limited theatre time, increased patient age and the presence of underlying co-morbidities, rather than the aetiology or characteristics of the strictures alone.
